These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 11160455)

  • 21. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study.
    Wu Q; Reith ME; Walker QD; Kuhn CM; Carroll FI; Garris PA
    J Neurosci; 2002 Jul; 22(14):6272-81. PubMed ID: 12122086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study.
    Gerasimov MR; Franceschi M; Volkow ND; Gifford A; Gatley SJ; Marsteller D; Molina PE; Dewey SL
    J Pharmacol Exp Ther; 2000 Oct; 295(1):51-7. PubMed ID: 10991960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
    Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
    J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raclopride studies of dopamine release: dependence on presynaptic integrity.
    Doudet DJ; Holden JE
    Biol Psychiatry; 2003 Dec; 54(11):1193-9. PubMed ID: 14643086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism.
    Volkow ND; Tomasi D; Wang GJ; Telang F; Fowler JS; Logan J; Maynard LJ; Wong CT
    J Neurosci; 2013 Mar; 33(10):4527-35. PubMed ID: 23467368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
    Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
    J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N
    Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.
    Volkow ND; Swanson JM
    Am J Psychiatry; 2003 Nov; 160(11):1909-18. PubMed ID: 14594733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
    Chen BT; Rice ME
    J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder.
    Wang GJ; Wiers CE; Shumay E; Tomasi D; Yuan K; Wong CT; Logan J; Fowler JS; Volkow ND
    Transl Psychiatry; 2019 Feb; 9(1):93. PubMed ID: 30770780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings.
    Marcellino D; Kehr J; Agnati LF; Fuxe K
    Synapse; 2012 Mar; 66(3):196-203. PubMed ID: 22034017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of repeated measures of endogenous dopamine competition with [11C]raclopride in the human brain in response to methylphenidate.
    Wang GJ; Volkow ND; Fowler JS; Logan J; Pappas NR; Wong CT; Hitzemann RJ; Netusil N
    J Nucl Med; 1999 Aug; 40(8):1285-91. PubMed ID: 10450679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.
    Berry AS; Shah VD; Furman DJ; White RL; Baker SL; O'Neil JP; Janabi M; D'Esposito M; Jagust WJ
    Neuropsychopharmacology; 2018 May; 43(6):1201-1211. PubMed ID: 28816243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo.
    Wong DF; Harris JC; Naidu S; Yokoi F; Marenco S; Dannals RF; Ravert HT; Yaster M; Evans A; Rousset O; Bryan RN; Gjedde A; Kuhar MJ; Breese GR
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5539-43. PubMed ID: 8643611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new PET ligand for the dopamine transporter: studies in the human brain.
    Volkow ND; Ding YS; Fowler JS; Wang GJ; Logan J; Gatley SJ; Schlyer DJ; Pappas N
    J Nucl Med; 1995 Dec; 36(12):2162-8. PubMed ID: 8523098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.